Teriparatide vs EGF
Head-to-head comparison of Teriparatide (Parathyroid Hormone (1-34)) and EGF (Human Epidermal Growth Factor) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Teriparatide | EGF |
|---|---|---|
| Category | Recovery & Healing | Recovery & Healing |
| Full Name | Parathyroid Hormone (1-34) | Human Epidermal Growth Factor |
| Molecular Weight | 4117 Da | 6.0 kDa |
| Half-Life | about 1 hour | minutes |
| Amino Acids | 34 | 53 |
| Typical Dose | 20 mcg daily | 0.04–0.1 mg/cm²/day |
| Route | Subcutaneous | Topical |
| Purity | ≥98% | ≥98% |
| Studies Count | 1200 | 650 |
| Research Status | Clinical | Clinical |
Teriparatide Benefits
- ✓stimulates bone formation
- ✓supports fracture union
- ✓improves bone mineral density
- ✓may aid bone remodeling
EGF Benefits
- ✓re-epithelialization
- ✓fibroblast activation
- ✓angiogenesis support
- ✓faster ulcer closure
Teriparatide Dosing
20 mcg subcutaneous daily|intermittent anabolic exposure|monitor calcium and vitamin D status
EGF Dosing
Topical daily|0.04–0.1 mg/cm²|short courses until granulation/closure
Teriparatide Side Effects
- ⚠hypercalcemia
- ⚠nausea
- ⚠dizziness
EGF Side Effects
- ⚠local irritation
- ⚠erythema
- ⚠theoretical hyperproliferation
- ⚠pain at site
Research Overview
Teriparatide
Teriparatide has extensive clinical literature showing anabolic effects on bone and investigational use in delayed unions and nonunions. It is one of the best-studied peptide-based options for skeletal recovery.
EGF
Human and animal studies show EGF can accelerate epithelial migration and wound closure, especially in burns, ulcers, and mucosal injury. Its best evidence is for topical or local delivery because systemic exposure is brief and the effect is highly localized.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.